Severe gastrointestinal adverse reactions were reported in 4.1% and 0.9% of WEGOVY injection and placebo-treated patients, respectively, and in 2% of WEGOVY tablet-treated and 0% of placebo-treated patients, respectively
No certificates of analysis were posted, many products lacked the required FDA disclaimer, and many products used deceptive advertising
Moving forward, combining natural product research with computational drug discovery, precision medicine, and innovative drug formulations will enhance therapeutic efficacy and accelerate clinical translation
Your provider may keep you at the same dose longer if you are still experiencing side effects or have not yet stabilized
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Lipotropic agents are compounds that help the body break down and metabolize fats